Cormorant Asset Management »

Arcutis Biotherapeutics shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $24M 2.5M 9.30
2024-03-31 $21M 2.1M 9.91
2023-06-30 $7.6M 800k 9.53
2022-12-31 $9.6M 650k 14.80
2022-09-30 $19M 1.0M 19.11

More positions owned by Cormorant Asset Management

Moonlake Immunotherapeutics Class A Ord (MLTX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Arcellx Common Stock (ACLX)
Vaxcyte (PCVX)
Longboard Pharmaceuticals In (LBPH)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Merus N V (MRUS)
Bridgebio Pharma (BBIO)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Janux Therapeutics (JANX)
Axsome Therapeutics (AXSM)

View all positions for Cormorant Asset Management

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
BlackRock
Frazier Life Sciences Management
BlackRock
Vanguard Group
State Street Corporation
Franklin Resources
Morgan Stanley
Citadel Advisors
Cormorant Asset Management
Geode Capital Management
Ensign Peak Advisors
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics